Tunca Fatih, Akici Murat, Işcan Yalın, Cem Sormaz Ismail, Giles Senyurek Yasemin, Terzioğlu Tarık
Department of General Surgery, Faculty of Medicine, Istanbul University, Istanbul, Turkey -
Department of General Surgery, Faculty of Medicine, Afyon Kocatepe University, Erenler, Turkey.
Minerva Endocrinol. 2017 Sep;42(3):213-222. doi: 10.23736/S0391-1977.16.02396-8. Epub 2016 Feb 10.
The impact of single and combined interpretations of ultrasonography and sestamibi scintigraphy to select the appropriate surgical approach in patients with primary hyperparathyroidism were evaluated retrospectively.
A total of 183 patients with primary hyperparathyroidism who were evaluated preoperatively using both ultrasonography and sestamibi scintigraphy were included in the study. The results of preoperative localization studies were correlated with intraoperative findings and postoperative histopathological results. The localization rates of individual and combined interpretations of ultrasonography and sestamibi scintigraphy were evaluated.
The overall sensitivity and the positive predictive value of ultrasonography and sestamibi scintigraphy were 76% and 90%, and 81% and 91%, respectively. Both imaging studies were concordant for the same localization(s) in 121 (66%) of 183 patients. The prevalence rates of single-gland and multiglandular disease were 90% (N.=109) and 10% (N.=12), respectively, in patients with concordant results (P=0.0001). The overall rate of localization was 91% (N.=110) in these patients. In these patients with concordant results, the sensitivity and the positive predictive value of imaging were 91% and 100%, respectively. The localization rates were 96% and 42% for single-gland and multiglandular disease, respectively (P=0.0001). Of the remaining 62 patients, 50 had negative imaging with either ultrasonography (N.=29) or MIBI (N.=21). Of the 29 patients with negative ultrasonography results, sestamibi scintigraphy was positive in 23. Of the 21 patients with negative sestamibi scintigraphy imaging, ultrasonography was positive in 15. Thus, 38 patients had a single positive imaging result. The majority (95%) of these 38 patients had single-gland disease, and the rate of multiglandular disease was 5% (P=0.0001). The rate of localization was 95% (36/38) in patients with a single positive imaging study. Eighteen patients had discordant imaging results.
The overall rate of localization in primary hyperparathyroidism is greater than 90% if ultrasonography and sestamibi scintigraphy are concordantly positive for the same localization, and the prevalence of multiglandular disease is low in patients with concordant imaging. An image-guided surgical approach and selective parathyroidectomy exhibit high cure rates in the setting of concordantly positive sestamibi and ultrasonography results, even if intraoperative parathormone monitoring is not used.
回顾性评估超声检查和锝-99m甲氧基异丁基异腈(MIBI)闪烁扫描单独及联合解读对选择原发性甲状旁腺功能亢进症患者合适手术方式的影响。
本研究纳入183例术前同时接受超声检查和MIBI闪烁扫描评估的原发性甲状旁腺功能亢进症患者。术前定位研究结果与术中发现及术后组织病理学结果相关联。评估超声检查和MIBI闪烁扫描单独及联合解读的定位率。
超声检查和MIBI闪烁扫描的总体敏感度和阳性预测值分别为76%和90%,以及81%和91%。在183例患者中的121例(66%)中,两种影像学检查对相同定位的结果一致。结果一致的患者中,单腺体疾病和多腺体疾病的患病率分别为90%(n = 109)和10%(n = 12)(P = 0.0001)。这些患者的总体定位率为91%(n = 110)。在这些结果一致的患者中,影像学检查的敏感度和阳性预测值分别为91%和100%。单腺体疾病和多腺体疾病的定位率分别为96%和42%(P = 0.0001)。其余62例患者中,50例超声检查(n = 29)或MIBI(n = 21)的影像学检查结果为阴性。在29例超声检查结果为阴性的患者中,23例MIBI闪烁扫描为阳性。在21例MIBI闪烁扫描影像学检查结果为阴性的患者中,15例超声检查为阳性。因此,38例患者有单一阳性影像学检查结果。这38例患者中的大多数(95%)患有单腺体疾病,多腺体疾病的发生率为5%(P = 0.0001)。单一阳性影像学检查的患者定位率为95%(36/38)。18例患者的影像学检查结果不一致。
如果超声检查和MIBI闪烁扫描对相同定位均为阳性,则原发性甲状旁腺功能亢进症的总体定位率大于90%,且影像学检查结果一致的患者中多腺体疾病的患病率较低。在MIBI和超声检查结果均为阳性的情况下,即使不使用术中甲状旁腺激素监测,图像引导下的手术方式和选择性甲状旁腺切除术也具有较高的治愈率。